Tournament: SeptOct LD | Round: 1 | Opponent: All | Judge: Any
First off is the innovation disadvantage.
Uniqueness: Pharma profits are up from COVID vaccines, but patent waivers threaten this.
Buchholz 5-17-21
(Katharina, https://www.statista.com/chart/24829/net-income-profit-pharma-companies/)
The profitability of coronavirus vaccines has been in the spotlight since U.S.
AND
almost $428 million accrued in the first nine months of the year.
Link: Strong IP protections spur innovation by encouraging risk-taking and incentivizing knowledge sharing. You should prefer our statistical analysis of multiple studies.
Ezell and Cory 19 Stephen Ezell, vice president and global innovation policy @ ITIF, BS Georgetown School of Foreign Service. Nigel Cory, associate director covering trade policy @ ITIF, MA public policy @ Georgetown. "The Way Forward for Intellectual Property Internationally," Information Technology and Innovation Foundation, 4-25-2019, accessed 8-25-2021, https://itif.org/publications/2019/04/25/way-forward-intellectual-property-internationally HWIC
IPRs Strengthen Innovation
Intellectual property rights power innovation. For instance, analyzing the
AND
for foreign direct investment which in turn also leads to economic growth.”56
Internal link: Biopharmaceutical innovation is key to prevent future pandemics and bioterror attacks.
Marjanovic and Feijao 20 Sonja Marjanovic Ph.D., Judge Business School, University of Cambridge. Carolina Feijao, Ph.D. in biochemistry, University of Cambridge; M.Sc. in quantitative biology, Imperial College London; B.Sc. in biology, University of Lisbon. "How to Best Enable Pharma Innovation Beyond the COVID-19 Crisis," RAND Corporation, 05-2020, accessed 8-8-2021, https://www.rand.org/pubs/perspectives/PEA407-1.html HWIC
As key actors in the healthcare innovation landscape, pharmaceutical and life sciences companies have
AND
such public health threats to an even greater extent under improved innovation conditions.
Impact: Advanced bioweapons causes extinction, which outweighs the affirmative.
Millett and Snyder-Beattie ‘17. Millett, Ph.D., Senior Research Fellow, Future of Humanity Institute, University of Oxford; and Snyder-Beattie, M.S., Director of Research, Future of Humanity Institute, University of Oxford. 08-01-2017. “Existential Risk and Cost-Effective Biosecurity,” Health Security, 15(4), PubMed
In the decades to come, advanced bioweapons could threaten human existence. Although the
AND
and Japan using plague to cause an epidemic in China during WWII.27
Now I will move onto the aff’s case.
On-case: Inequality Contention
- Existing compulsory licensing exemptions are sufficient to solve, which means there is no need for the affirmative’s plan.
Bacchus, JD, 20
(James, adjunct scholar at the Cato Institute, a professor of global affairs at the University of Central Florida, An Unnecessary Proposal A WTO Waiver of Intellectual Property Rights for COVID-19 Vaccines https://www.cato.org/sites/cato.org/files/2020-12/FTB_78.pdf, 12-16)
What we have not heard in the waiver debate is any clear explanation from waiver
AND
action should be no broader than necessary to address the global medical need.
3. IP protections don’t cause disease spread because patent incidence is low and independently increases access- prefer empirics.
Stevens 04 Philip Stevens, Director of Health Projects at the International Policy Network. “Diseases of poverty and the 10/90 Gap.” November 2004. https://www.who.int/intellectualproperty/submissions/InternationalPolicyNetwork.pdf AL
Much debate on this issue of access has centred around the claim that patents held
AND
the list were originally discovered and/or developed by private companies.31
5. No US-China war- strong domestic incentives to prioritize stability and growth.
Asen ‘19
(Eric, StudyingPoliSciandEconomics@VanderbiltUniversity, https://nationalinterest.org/blog/skeptics/china-not-interested-war-america-54042, April 24) BW
The strained relationship between China and the United States appears to worsen with each passing
AND
national security fears aren’t urgent enough to make the public demand a showdown.
2. Reducing IP rights does not solve quickly enough to help the pandemic because legal battles will slow the process – experts agree.
Smith 05/05
(Laura Smith-Spark; Newsdesk Editor, CNN Digital; (05-05-21) Rich nations urged to share vaccine knowledge while WTO debates waiving patents; CNN; https://www.cnn.com/2021/05/05/world/covid-19-vaccine-patents-wto-intl/index.html; CKD)
But even as public pressure grows, some experts argue that handing over the IP
AND
their arms in the fastest and most efficient way possible," he said.
3. The WTO has already published how to make COVID vaccines, which proves the status quo solves.
Taylor 8-5-21 (Nick Taylor Journalist specializing in the biopharma industry, Biopharma Reporter, WTO lists critical inputs for COVID-19 vaccines to address gaps in global supply, 8/5/21, https://www.biopharma-reporter.com/Article/2021/08/05/WTO-lists-critical-inputs-for-COVID-19-vaccines?utm_source=copyrightandutm_medium=OnSiteandutm_campaign=copyright) hwof
The World Trade Organization (WTO) Secretariat has published a list of critical inputs
AND
, the Coalition for Epidemic Preparedness Innovations and DHL jointly produced the list.
5. The aff does not solve. Focusing on vaccine equity obscures vaccine “rollout” issues
Adler 7-20-21
(David Adler is the author of The New Economics of Liquidity and Financial Frictions and co-editor of the anthology The Productivity Puzzle: Restoring Economic Dynamism, both published by the CFA Institute Research Foundation. He is also an adviser on industrial strategy at the Common Good Foundation in the United Kingdom. https://foreignpolicy.com/2021/07/20/wto-trips-waiver-vaccine-equity-distribution-covid-pandemic/)
On July 20, the World Trade Organization holds another Trade-Related Aspects of
AND
South Africa whose industrial policies have long called for limitations on IP rights.